Intervention

Hepatitis B Vaccine (Recombinant)

ClinicalTrials.gov intervention label

Clinical trials5
Recruiting0
Common conditions5
Lead sponsors shown1

Clinical trials

5 shown
Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIVNCT00001119 · 1999-10-01
COMPLETED
A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160NCT00000745
COMPLETED
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive IndividualsNCT00000633
COMPLETED
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugsNCT00013871
COMPLETED
A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328NCT00000943
COMPLETED

Trial status mix

COMPLETED5

Phase mix

NA3
PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.